However, high levels of follicle-stimulating hormone (FSH), along with the vasodilation and somatic symptoms of perimenopausal women, are known to increase the risk of anxiety and depression (Yanyan 2012). This evidence concerns the gene BRD2 and depressive symptom measurement.